Biological effects of nonthermal plasma combined with Xray irradiation on human hepatocellular carcinoma in nude mice

doi:10.3760/cma.j.issn.1673422X.2017.04.004

Abstract

Abstract: Objective To investigate the biological effects of nonthermal plasma (NTP) combined with X-ray irradiation on human hepatocellular carcinoma in nude mice. Methods By subcutaneous inoculation, tumor models of human hepatocellular carcinoma HepG2 in nude mice were established, and these mice were divided into control group, NTP treatment group, X-ray irradiation group, combined treatment group. The changes of tumor microenvironment were observed using hematoxylineosin (HE) staining. The terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) was used to determine the level of neuronal apoptosis in tumor tissues. The expression of metal matrix proteinase-2 (MMP-2) was detected by immunohistochemical assay. Transmission electron microscope was used to observe cell structure changes. Results The final tumor volumes of control group, NTP treatment group, X-ray irradiation group, combined treatment group were (543.96±108.45), (436.54±65.49), (351.66±56.68), (281.97±35.60)mm3, with a statistically significant difference (F=9.63, P=0.01), and the difference between X-ray radiation group and the combination treatment group was significant (P=0.05). HE staining showed that there was a larger area of necrosis in the combined treatment group compared with the other groups. TUNEL showed that the apoptotic indexes were (0.95±0.13)%, (5.82±0.26)%, (7.53±0.43)%, (11.07±0.35)% respectively, with a statistically significant difference (F=547.76, P=0.00), and the difference between X-ray radiation group and the combination treatment group was statistically significant (P=0.00). The immune scores of each group were 12, 9, 9, 2. Electron microscopic observation showed that there were more apoptotic bodies in the combined treatment group than those in the other groups, accompanied by mitochondrial edema. Conclusion NTP and X-ray irradiation therapy in the treatment of human hepatocellular carcinoma in nude mice model has a synergistic effect. Probably, it can be a new type of treatment in curing cancers.

Key words: Radiotherapy, Liver neoplasms, Nonthermal plasma

Chen Chen, Zhou Juying. Biological effects of nonthermal plasma combined with Xray irradiation on human hepatocellular carcinoma in nude mice[J]. Journal of International Oncology, 2017, 44(4): 257-261.

References

［1］ Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric Argon plasma in chronic wounds: results of a randomized controlled trial［J］. Br J Dermatol, 2012, 167(2): 404-410. DOI: 10.1111/j.1365-2133.2012.10923.x. ［2］ Donadelli M, Dando I, Zaniboni T, et al. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism［J］. Cell Death Dis, 2011, 2: e152. DOI: 10.1038/cddis.2011.36. ［3］ Kaushik N, Lee SJ, Choi TG, et al. Nonthermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells［J］. Sci Rep, 2015, 5: 8726. DOI: 10.1038/srep08726. ［4］ Kang SU, Cho JH, Chang JW, et al. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogenactivated protein kinasedependent mitochondrial reactive Oxygen species［J］. Cell Death Dis, 2014, 5: e1056. DOI: 10.1038/cddis.2014.33. ［5］ Keidar M, Shashurin A, Volotskova O, et al. Cold atmospheric plasma in cancer therapy［J］. Phys Plasmas, 2013, 20(5): 4801516. DOI: 10.1063/1.4801516. ［6］ Yajima I, Iida M, Kumasaka MY, et al. Nonequilibrium atmospheric pressure plasmas modulate cell cyclerelated gene expressions in melanocytic tumors of RET-transgenic mice［J］. Exp Dermatol, 2014, 23(6): 424-425. DOI: 10.1111/exd.12415. ［7］ Iida M, Omata Y, Nakano C, et al. Decreased expression levels of cell cycle regulators and matrix metalloproteinases in melanoma from RET-transgenic mice by single irradiation of non-equilibrium atmospheric pressure plasmas［J］. Int J Clin Exp Pathol, 2015, 8(8): 9326-9331. ［8］胡超, 钱丹琪, 秦颂兵, 等. NTP联合辐射对三种癌细胞系放射增敏效应的研究［J］. 中华放射医学与防护杂志, 2015, 35(11): 819824. DOI: 10.3760/cma.j.issn.02545098.2015.11.005. ［9］ Fridman G, Friedman G, Gutsol A, et al. Applied plasma medicine［J］. Plasma Process Polym, 2008, 5(6): 503533. DOI: 10.1002/ppap.200700154. ［10］ Stoffels E, Flikweert AJ, Stoffels WW, et al. Plasma needle: a nondestructive atmospheric plasma source for fine surface treatment of (bio) materials［J］. Plasma Sources Sci Technol, 2002, 11(4): 383388. DOI: 10.1088/09630252/11/4/304. ［11］ Keidar M, Walk R, Shashurin A, et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy［J］. Br J Cancer, 2011, 105(9): 12951301. DOI: 10.1038/bjc.2011.386. ［12］ Vandamme M, Robert E, Lerondel S, et al. ROS implication in a new antitumor strategy based on nonthermal plasma［J］. Int J Cancer, 2012, 130(9): 21852194. DOI: 10.1002/ijc.26252. ［13］ Volotskova O, Stepp MA, Keidar M. Integrin activation by a cold atmospheric plasma jet［J］. New J Phys, 2012, 14(5): 1421. DOI: 10.1088/13672630/14/5/053019. ［14］ Omata Y, Iida M, Yajima I, et al. Nonthermal atmospheric pressure plasmas as a novel candidate for preventive therapy of melanoma［J］. Environ Health Prev Med, 2014, 19(5): 367369. DOI: 10.1007/s1219901403991.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei. Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study [J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[4]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[5]	Qian Xiaotao, Shi Ziyi, Hu Ge. A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2024, 51(3): 151-156.
[6]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174.
[7]	Peng Qin, Cai Yuting, Wang Wei. Advances on KPNA2 in liver cancer [J]. Journal of International Oncology, 2024, 51(3): 181-185.
[8]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[9]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[10]	Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong. Effects of Anhydroicaritin on the proliferation， migration and apoptosis of hepatocellular carcinoma cells [J]. Journal of International Oncology, 2023, 50(9): 513-519.
[11]	Cui Tenglu, Lyu lu, Sun Pengfei. Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(9): 548-552.
[12]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai. Research progress on the application of combining radiotherapy and systemic therapy in breast cancer [J]. Journal of International Oncology, 2023, 50(6): 362-367.
[13]	Lyu Lu, Sun Pengfei. Gut flora and cervical cancer [J]. Journal of International Oncology, 2023, 50(6): 373-376.
[14]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association. Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version） [J]. Journal of International Oncology, 2023, 50(4): 193-201.
[15]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng. Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance [J]. Journal of International Oncology, 2023, 50(4): 227-230.